Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 2

Sponsor Class

NIH 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2

Conditions

Neoplasms 8Prostatic Neoplasms 7Leukemia, Myeloid, Acute 6Colorectal Neoplasms 5Breast Neoplasms 5Stomach Neoplasms 4Leukemia, Myelomonocytic, Acute 4Leukemia, Monocytic, Acute 4Leukemia, Megakaryoblastic, Acute 4Leukemia, Erythroblastic, Acute 4Congenital Abnormalities 4Pancreatic Neoplasms 3Multiple Myeloma 3Lymphoma, Mantle-Cell 3Lung Neoplasms 3Colonic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Venous Thromboembolism 2Recurrence 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Papillomavirus Infections 2Neuroblastoma 2Neoplasm Metastasis 2Motor Activity 2Melanoma 2Lymphoma, Follicular 2Lymphoma 2Leukemia, Eosinophilic, Acute 2Leukemia, Basophilic, Acute 2

Interventions

Cytarabine 17Filgrastim 6Daunorubicin 6tipifarnib 5Etoposide 5Clofarabine 5Idarubicin 4Gene Expression Profiling 4Gemtuzumab 4Cyclophosphamide 4Radiotherapy 3Peripheral Blood Stem Cell Transplantation 3Mitoxantrone 3Flow Cytometry 3Busulfan 3Arsenic Trioxide 3fludarabine phosphate 2aldesleukin 2Thiotepa 2Sorafenib 2Observation 2Melphalan 2Imatinib Mesylate 2Antilymphocyte Serum 2valspodar 1temsirolimus 1tanespimycin 1sargramostim 1romidepsin 1laromustine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Leukemia, Basophilic, Acute × Observation × Clear all
NCT00085709 2015-09-30

S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML

SWOG Cancer Research Network

Phase 3 Completed
637 enrolled 7 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

NCT00006363 2013-06-04

Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 3 Completed
720 enrolled
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡